about
A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulationCurrent investigational drugs for major depressionCritical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adultsA benefit-risk assessment of agomelatine in the treatment of major depression.Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders.Melatonergic drugs in development.Depressive Symptoms and 24-Hour Ambulatory Blood Pressure in Africans: The SABPA Study.Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products of agomelatine in Chinese subjects.The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice.Agomelatine, a melatonin agonist with antidepressant properties.Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism.Agomelatine for the treatment of major depressive disorder.Cardiovascular effects of melatonin receptor agonists.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders.Pharmacokinetic evaluation of agomelatine for the treatment of generalised anxiety disorder.New insights on the antidepressant discontinuation syndrome.Chronic fluoxetine treatment increases daytime melatonin synthesis in the rodent.The Black Book of Psychotropic Dosing and Monitoring.Agomelatine: an antidepressant with new potent hepatoprotective effects on paracetamol-induced liver damage in rats.Does agomelatine block 5-HT2C receptors in humans?
P2860
Q22305782-B3DC1C7D-33A5-4A86-BFC1-10580823053BQ28244223-3656AC06-B148-4F29-B745-1A8C800DAACEQ28764080-485496C8-ECF9-4DAE-A7FE-C2E10364E08BQ34207131-16B21DDF-5818-44DD-8A17-4D1C925685CDQ34358480-E71A2633-886D-423F-879C-5F1031BE4C89Q34440574-7ACBE9F4-24F3-451C-A5EA-DC55B460210DQ35418546-00E5A4C2-6ACD-4D63-B54A-1D75F415B45AQ36495583-F988D599-1FE1-40AB-85BF-B3BBD54EA13AQ37007350-7968D157-7F09-4094-978F-A01937BB5733Q37598264-452F9009-0789-4BC2-A8EC-3D1397F5AB1FQ37898706-241D322E-E2AB-4990-BD50-1A3227AA8E96Q37931969-62A989A1-16A0-4B63-BB58-D0882AE87ECEQ38037124-3AAD99DD-2218-4DA6-8F9F-49ADF8192778Q38123516-A8700979-8FA8-43F6-A619-B823C63FC7E8Q38203356-EC61938D-C2D7-43D6-A575-9C1D23F4C283Q38238790-222E3EA6-6BAE-4E52-AABD-74DE21F43E5BQ40540771-F86CB756-05AF-4DB3-A58B-D2D8528B79D6Q47642128-840C5E96-A309-4CDD-95ED-EF09ECFA6343Q48183450-4CBB2F15-0127-4583-A569-F4F937DD47FDQ48343728-7201A0C4-1614-434B-8FD7-DDE777C0DD86
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Agomelatine treatment of major depressive disorder.
@ast
Agomelatine treatment of major depressive disorder.
@en
Agomelatine treatment of major depressive disorder.
@nl
type
label
Agomelatine treatment of major depressive disorder.
@ast
Agomelatine treatment of major depressive disorder.
@en
Agomelatine treatment of major depressive disorder.
@nl
prefLabel
Agomelatine treatment of major depressive disorder.
@ast
Agomelatine treatment of major depressive disorder.
@en
Agomelatine treatment of major depressive disorder.
@nl
P2093
P2860
P356
P1476
Agomelatine treatment of major depressive disorder.
@en
P2093
Christian R Dolder
Michael Nelson
Morgan Snider
P2860
P304
P356
10.1345/APH.1L296
P407
P577
2008-11-25T00:00:00Z